Radius Health, Inc. Uncategorized Contracts & Agreements
58 Contracts & Agreements
- Form of Contingent Value Rights Agreement to be entered into between Ginger Acquisition, Inc. and a Rights Agent (Filed With SEC on June 23, 2022)
- Offer Letter between the Company and Mark Conley (Filed With SEC on March 16, 2022)
- Surrender Agreement, dated May 19, 2021, by and between Rovi Corporation and Radius Health, Inc (Filed With SEC on May 21, 2021)
- Senior Advisor Agreement between the Company and Jesper Hoeiland (Filed With SEC on April 28, 2020)
- Inducement Option Agreement (Time-Based Option) between the Company and G. Kelly Martin (Filed With SEC on April 28, 2020)
- Description of Securities (Filed With SEC on February 27, 2020)
- Option Type (Filed With SEC on May 15, 2017)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 32 (Filed With SEC on August 4, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 31 (Filed With SEC on August 4, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 30 (Filed With SEC on August 4, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 29 (Filed With SEC on August 4, 2016)
- QUALITY AGREEMENT for the Manufacture of an application system pre-filled with abaloparatide in a solution, by and between RADIUS HEALTH, INC. and VETTER PHARMA-FERTIGUNG GMBH &... (Filed With SEC on August 4, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 (Filed With SEC on August 4, 2016)
- WORK ORDER NO. 13 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 12 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 11 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 10 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 9 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 8 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 4 (Filed With SEC on May 5, 2016)
- AMENDMENT NO.3 to WORK ORDER NO.2 (Filed With SEC on May 5, 2016)
- WORK ORDER NO.2 (Filed With SEC on May 5, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 13 (Filed With SEC on November 5, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 23 version 2 (Filed With SEC on November 5, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 12 (Filed With SEC on November 5, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 11 (Filed With SEC on November 5, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 10 (Filed With SEC on August 6, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 9 (Filed With SEC on August 6, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 8 (Filed With SEC on August 6, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 26 (Filed With SEC on August 6, 2015)
- FIFTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on April 30, 2014)
- FIFTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on April 25, 2014)
- Orbit Advisers Limited (Filed With SEC on February 28, 2014)
- FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on February 21, 2014)
- Radius Health, Inc. 201 Broadway, 6th Floor Cambridge, MA 02139 (Filed With SEC on February 3, 2014)
- [signature page follows] (Filed With SEC on November 29, 2013)
- THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on April 25, 2013)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 (Filed With SEC on March 15, 2013)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 (Filed With SEC on March 15, 2013)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 (Filed With SEC on March 15, 2013)
